Although gene editing has enormous clinical promise, it still faces many obstacles that must be overcome before broad translation. For example, the genome editing field is continuously working to ...

The latest update to the ESM protein language model series supports binder design and protein function mapping for therapeutic discovery.

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.

By developing their own functional nerves, these organoids demonstrate how engineering principles can drive biological ...

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets ...

Roughly 2700 attendees heard a range of perspectives from experts in precision medicine, bioinformatics, and rare disease ...

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.

Researchers suggest targeting mTOR activity in aggressive cancers by blocking cholesterol sensing may represent a promising ...

The Copenhagen-based team is building an AI platform to target underexplored GPCRs to treat diseases once deemed undruggable.

By mapping how genes relate to one another across biological situations, GSFM creates a reference framework that can help ...

New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new screening system for targeting receptors long ...